Significant Morbidity Associated with Bone Metastases in a Patient with Breast Cancer

Galasko CSB . Incidence and distribution of skeletal metastases. Clin Orthoped 1986; 210: 14–21.

Folstein MF , Folstein S , McHugh PR . Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–198.

Bruera E , Macmillan K , Hanson J , MacDonald RN . The Edmonton staging system for cancer pain: preliminary report. Pain 1989; 37: 203–209.

Ewing JA . Detecting alcoholism: the CAGE questionnaire. JAMA 1984; 252: 1905–1907.

Langmuir VK , Pulter CA , Qazi R , Savlov ED . Breast Cancer. In: Rubin P (ed). Clinical Oncology A Multidisciplinary Approach for Physicians and Students, 7th edition. Philadelphia: WB Saunders Co., 1993; pp. 187–215.

Pollak M. Hormonal therapies for breast cancer. Curr Oncol 1996; 3: 546–552.

Paterson AH , Powles TJ , Kanis JA , . Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J Clin Oncol 1993; 11: 59–65.

Van Holten-Verzantvoot AT , Kroon HM , Bijvoet HM , . Palliative Pamidronate treatment in patients with bone metastases from breast cancer. J Clin Oncol 1993; 11: 491–498.

Houston SJ , Rubens RD . The systemic treatment of bone metastases. Clin Orthoped Rel Res 1995; 312: 95–104.

Hoskin PJ . Radiotherapy in the management of bone pain. Clin Orthoped Rel Res 1995; 312: 105–119.

Cheng DS , Seitz CB , Eyre HJ . Non-operative management of femoral, humeral, and acetabular metastases in patients with breast cancer. Cancer 1980; 45: 1533–1537.

Robinson RG , Blake GM , Preston DF , . Strontium-89 treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone. Radiographics 1989; 9: 271–281.

Dusing RW , Preston DF , Baxter KG , . Strontium-89 chloride for pain palliation in the skeletal metastases of breast cancer. Clin Nucl Med 1993; 18: 624.

Morant R , Senn H-J. The management of infections in palliative care. In: Doyle D , Hanks G , MacDonald N (eds). Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press, 1993; pp. 378–384.

Hipp JA , Springfield DS , Hayer WC . Predicting pathologic fracture risk in the management of metastatic bone defects. Clin Orthoped Rel Res 1995; 312: 136–147.

Harrington K. Orthopaedic management of extremity and pelvic lesions. Clin Orthoped Rel Res 1995; 312: 136–147.

Harrington K , Sim FH , Enis JE , . Methylmethacrylate as an adjunct in internal fixation of pathological fractures: experience with 375 cases. J Bone Joint Surg 1976; 58A: 1047–1055.

Bunting RW , Boublik M , Blevins FT , . Functional outcome of pathologic fracture secondary to malignant disease in a rehabilitation hospital. Cancer 1992; 69: 98–102.

Orr FW , Sanchez-Sweatman OH , . Tumor-bone interactions in skeletal metastases. Clin Orthoped Rel Res 1995; 312: 19–33.